Characteristics associated with death in patients with atrial fibrillation initiated on rivaroxaban and followed up for 1 year on treatment - an analysis in the pooled XANTUS data

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial Fibrillation - Stroke Prevention Oral Anticoagulation EHRA Premium Access EHRA 2019

ESC 365 is supported by

ESC 365 is supported by